Maiuthed et al. used bioinformatic analysis and pharmacology experiments to verify the underlying regulatory mechanisms of MRPs on lung cancer and found a more than 5-fold increase in MRPL51 expression in a lung cancer cell model [51]. This evidence concerns the gene MRPL51 and lung cancer.